PMID: 11343498May 18, 2001Paper

Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998

Archives of Pediatrics & Adolescent Medicine
J L Rushton, J T Whitmire

Abstract

Presciption trends have key implications for costs, outcomes, and research, yet few data exist on pediatric selective serotonin reuptake inhibitor (SSRI) trends and associations with stimulant trends. To describe prescription trends for stimulants, SSRIs, and combination prescriptions by age, sex, and race. Retrospective population-based analysis of North Carolina Medicaid prescription claims files. North Carolina Medicaid recipients, 1992 through 1998, aged 1 to 19 years. The population ranged from 342 333 children in 1992 to 581 088 in 1998. Annual number of prescriptions, patients filling a prescription claim, and prescription prevalence for stimulants and SSRIs. The number of children and adolescents who received stimulants increased from 6407 (24 584 claims) in 1992 to 27 951 (135 057 claims) in 1998. The number of SSRI recipients increased from 510 children (1326 claims) in 1992 to 6984 children (25 392 claims) in 1998. Prescription prevalence in school-aged children 6 to 14 years increased from 4.4% to 9.5% for stimulants during the study period, and from 0.2% to 1.5% for SSRIs. In 1998, stimulant prescription prevalence was highest for white school-aged males (18.3%) vs black females (3.4%) and SSRI prescription prevale...Continue Reading

Citations

Apr 13, 2011·Child Psychiatry and Human Development·J FreemanM Franklin
Feb 22, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Wendy Klein-Schwartz, Jean McGrath
Oct 24, 2007·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Shaheen E Lakhan, Gareth E Hagger-Johnson
Jan 21, 2009·Child and Adolescent Psychiatry and Mental Health·Erik Parens, Josephine Johnston
Feb 3, 2009·Child and Adolescent Psychiatry and Mental Health·Jennifer B FreemanMartin E Franklin
Jun 6, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Lisa A Strohschein
Jul 15, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Brandon L WarrenCarlos A Bolaños-Guzmán
Mar 17, 2006·Journal of American College Health : J of ACH·Sean Esteban McCabeCarol J Boyd
Apr 15, 2008·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Ty S SchepisRobert F Forman
Mar 28, 2007·Disease-a-month : DM·Donald E GreydanusDilip R Patel
Nov 8, 2008·Annals of the New York Academy of Sciences·Donald L Gilbert
Sep 24, 2004·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Susan L Andersen, Carryl P Navalta
May 13, 2004·The American Journal of Emergency Medicine·S David Baker, D L Morgan
Jun 6, 2003·Seminars in Pediatric Neurology·Robert L Rodnitzky
Sep 21, 2005·Child and Adolescent Psychiatric Clinics of North America·Shauna P Reinblatt, John T Walkup
Oct 16, 2003·Pediatric Clinics of North America·Donald E GreydanusMarsha D Rappley
Jan 11, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Andréa Dâmaso BertoldiPedro Curi Hallal
Nov 5, 2014·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Seanna E McMartinIan Colman
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·Laurel A HabelGlen Elliott
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·Ramesh RaghavanJohn Landsverk
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·Susan dosReisPamela L Owens
Feb 16, 2005·Expert Opinion on Drug Safety·Robert L Rodnitzky
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·J M Zito, D J Safer
May 25, 2005·Journal of Child and Adolescent Psychopharmacology·Paul H LipkinStewart H Mostofsky
Dec 2, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J John MannKaren D Wagner
Mar 3, 2006·Journal of Developmental and Behavioral Pediatrics : JDBP·William J BarbaresiSteven J Jacobsen
Jan 6, 2007·Psychopharmacology·Shauna P Reinblatt, Mark A Riddle
Jan 22, 2010·Community Mental Health Journal·Betsy SleathTim Carey
Dec 6, 2011·International Journal of Psychiatry in Clinical Practice·Vlatka Boričević MaršanićBranimir Margetić
Jan 24, 2014·Psychopharmacology·Lyonna F AlcantaraCarlos A Bolaños-Guzmán
Jun 7, 2014·Journal of Child and Family Studies·Sharon L BrennerElizabeth M Z Farmer
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Feb 28, 2004·PharmacoEconomics·Cynthia L Leibson, Kirsten Hall Long
Mar 7, 2007·Health Affairs·Richard M SchefflerPeter Levine
Oct 28, 2003·Journal of Developmental and Behavioral Pediatrics : JDBP·Denise A ChaviraMartin T Stein
Sep 9, 2006·Journal of Child and Adolescent Psychopharmacology·Donald G FergusonMichael Raschick
May 11, 2007·Journal of Child and Adolescent Psychopharmacology·Marcia L ZuckermanJoseph Gonzalez-Heydrich
Sep 19, 2012·Expert Opinion on Pharmacotherapy·Clara Adegbite-AdeniyiRobert L Findling
Nov 30, 2012·The International Journal of Neuropsychopharmacology·Covadonga M Díaz-CanejaCarmen Moreno
Oct 9, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ian C K WongMacey L Murray
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·Farifteh Firoozmand DuffyDarrel A Regier
Jan 12, 2005·Depression and Anxiety·Denise A ChaviraMartin T Stein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.